4//SEC Filing
Vogt Frederick G 4
Accession 0001104659-25-049999
CIK 0001425205other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:05 PM ET
Size
5.3 KB
Accession
0001104659-25-049999
Insider Transaction Report
Form 4
Vogt Frederick G
DirectorInterim CEO & General Counsel
Transactions
- Purchase
Common Stock
2025-05-14$1.69/sh+25,000$42,250→ 374,646 total
Footnotes (1)
- [F1]Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001719678
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:05 PM ET
- Size
- 5.3 KB